Yatiri Bio Investor Day

Yatiri Bio is at a compelling value inflection point, having generated unprecedented evidence that its platform can accurately predict patient outcomes for a known therapeutic. The company is advancing an investigator-initiated oncology trial at Fred Hutch designed to generate early clinical and biomarker validation, while simultaneously finalizing the in-licensing of a differentiated, Phase 2 clinical-stage therapeutic asset. This private investor briefing will highlight a focused, execution-driven near-term strategy, clearly defined value-creating milestones, and how targeted capital will accelerate initiation of the Fred Hutch trial and position the company for rapid transition into a pivotal Phase 2 program. We look forward to engaging with potential investors on a clear plan to create meaningful near-term value and accelerate the company’s next phase of growth.

You can either join in person or online using this link (https://teams.microsoft.com/meet/26195256490932?p=1O2VxK7kPnE67lKbz8).

Event Venue & Nearby Stays

6335 Nancy Ridge Dr, 6335 Nancy Ridge Drive, San Diego, United States

Concerts, fests, parties, meetups - all the happenings, one place.

Get App